Adams Respiratory Therapeutics, Inc. - Statement of Ownership (SC 13G)
15 Enero 2008 - 12:55PM
Edgar (US Regulatory)
|
|
OMB APPROVAL
|
|
UNITED
STATES
|
OMB Number: 3235-0145
|
|
SECURITIES
AND EXCHANGE COMMISSION
|
Expires: February 28, 2009
|
|
Washington,
D.C. 20549
|
Estimated average burden hours per response. . 10.4
|
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment No. )*
ADAMS
RESPIRATORY THERAPEUTICS, INC.
(Name of Issuer)
(Title of Class of
Securities)
(CUSIP Number)
(Date of Event
Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
x
|
Rule 13d-1(b)
|
o
|
Rule 13d-1(c)
|
o
|
Rule 13d-1(d)
|
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
Persons who respond to the collection of
information contained in this form are not required to respond unless the form
displays a currently valid OMB control number.
CUSIP No. 00635P107
|
|
|
1.
|
Names of Reporting
Persons. I.R.S. Identification Nos. of above persons (entities only)
Alger Associates, Inc. 13-3017981
Fred Alger Management, Inc. 13-2510833
|
|
|
2.
|
Check the Appropriate Box
if a Member of a Group (See Instructions)
|
|
|
(a)
|
o
|
|
|
(b)
|
x
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Citizenship or Place of
Organization
New York, New York
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5.
|
Sole Voting Power
2,006,000
|
|
6.
|
Shared Voting Power
-0-
|
|
7.
|
Sole Dispositive Power
2,006,000
|
|
8.
|
Shared Dispositive Power
-0-
|
|
|
9.
|
Aggregate Amount
Beneficially Owned by Each Reporting Person
2,006,000
|
|
|
10.
|
Check if the Aggregate
Amount in Row (9) Excludes Certain Shares (See Instructions)
o
|
|
|
11.
|
Percent of Class
Represented by Amount in Row (9)
5.57%
|
|
|
12.
|
Type of Reporting Person
(See Instructions)
Alger Associates, Inc. HC
Fred Alger Management, Inc. IA
|
|
|
|
|
|
|
2
CUSIP No. 00635P107
|
|
Item 1.
|
|
(a)
|
Name of Issuer
ADAMS RESPIRATORY THERAPEUTICS, INC.
|
|
(b)
|
Address of Issuers
Principal Executive Offices
4 MILL RIDGE LANE
CHESTER, NJ 07930
|
|
Item 2.
|
|
(a)
|
Name of Person Filing
1. Alger Associates,
Inc.
2. Fred Alger Management, Inc.*
|
|
(b)
|
Address of Principal
Business Office or, if none, Residence
111 Fifth Avenue, New York, NY 10003
|
|
(c)
|
Citizenship
New York
|
|
(d)
|
Title of Class of Securities
Common Stock
|
|
(e)
|
CUSIP Number
00635P107
|
|
Item 3.
|
If this statement is filed pursuant
to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is
a:
|
|
(a)
|
o
|
Broker or dealer
registered under section 15 of the Act (15 U.S.C. 78o).
|
|
(b)
|
o
|
Bank as defined in section
3(a)(6) of the Act (15 U.S.C. 78c).
|
|
(c)
|
o
|
Insurance company as
defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
(d)
|
o
|
Investment company
registered under section 8 of the Investment Company Act of 1940 (15 U.S.C
80a-8).
|
|
(e)
|
x
|
An investment adviser in
accordance with §240.13d-1(b)(1)(ii)(E);
|
|
(f)
|
o
|
An employee benefit plan
or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
(g)
|
o
|
A parent holding company
or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
|
(h)
|
o
|
A savings associations as
defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.
1813);
|
|
(i)
|
o
|
A church plan that is
excluded from the definition of an investment company under section 3(c)(14)
of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
|
(j)
|
o
|
Group, in accordance with
§240.13d-1(b)(1)(ii)(J).
|
*By virtue of the Alger
familys ownership of a controlling interest in Alger Associates, which
directly owns Fred Alger Management, Inc., ownership of the shares may be
imputed to the Alger family.
3
CUSIP No. 00635P107
|
|
Item 4.
|
Ownership
|
Provide the following
information regarding the aggregate number and percentage of the class of
securities of the issuer identified in Item 1.
|
|
(a)
|
Amount beneficially
owned:
2,006,000
|
|
(b)
|
Percent of class:
5.57%
|
|
(c)
|
Number of shares as to
which the person has:
|
|
|
(i)
|
Sole power to vote or to
direct the vote
2,006,000
|
|
|
(ii)
|
Shared power to vote or to
direct the vote
-0-
|
|
|
(iii)
|
Sole power to dispose or
to direct the disposition of
2,006,000
|
|
|
(iv)
|
Shared power to dispose or
to direct the disposition of
-0-
|
|
Item 5.
|
Ownership of Five Percent or Less
of a Class
|
If this statement is being filed to report the fact
that as of the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of securities, check
the following
o
.
|
|
Item 6.
|
Ownership of More than Five Percent
on Behalf of Another Person
|
n/a
|
|
Item 7.
|
Identification and Classification
of the Subsidiary Which Acquired the Security Being Reported on By the Parent
Holding Company
|
n/a
|
|
Item 8.
|
Identification and Classification
of Members of the Group
|
n/a
|
|
Item 9.
|
Notice of Dissolution of Group
|
n/a
|
|
Item 10.
|
Certification
|
(a) The following certification shall be
included if the statement is filed pursuant to s240.13d-1(b):
|
By signing below I certify that, to the best of my
knowledge and belief, the securities referred to above were acquired and are
held in the ordinary course of business and were not acquired and not held for
the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
4
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this
statement is true, complete and correct.
|
FRED ALGER MANAGEMENT,
INC.
|
|
|
|
By:
|
/s/ Hal Liebes
|
|
|
Executive Vice President
|
|
January 15, 2008
|
|
|
|
ALGER ASSOCIATES, INC.
|
|
|
|
By:
|
/s/ Hal Liebes
|
|
|
Director
|
|
January 15, 2008
|
The original statement shall be signed by each person on whose behalf
the statement is filed or his authorized representative. If the statement is
signed on behalf of a person by his authorized representative other than an
executive officer or general partner of the filing person, evidence of the
representatives authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference. The name and any title of each person who
signs the statement shall be typed or printed beneath his signature.
Note: Schedules filed in paper
format shall include a signed original and five copies of the schedule,
including all exhibits. See s240.13d-7 for other parties for whom copies are to
be sent.
ATTENTION. INTENTIONAL
MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE
18 U.S.C. 1001).
5
Adams Respiratory Therapeutics (NASDAQ:ARXT)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Adams Respiratory Therapeutics (NASDAQ:ARXT)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Adams Respiratory Therapeutics (MM) (NASDAQ): 0 recent articles
Más de Adams Respiratory Therapeutics, Inc. Artículos de Noticias